TriVascular Technologies, Inc. (TRIV)

[PerserNL]

TRIV +100%-price-target by analysts:


Stock Targets

Wall Street analysts covering the stock, on a consensus basis, have a one-year price target of $10.333 on the equity. This is based on the 3 individual recommendations by the firms tracked by Zacks. The most aggressive target sees the stock headed to $13 while the most bearish has a $9 target. Zacks also uses a method in order to simplify the various recommendations into a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Shares of TriVascular Technologies, Inc. currently have an average broker rating of 1. Three months ago when the same analysts were polled, the ABR was at 1

http://www.investornewswire.com/analyst-views/can-trivascular-technologies-inc-nasdaqtriv-post-an-earnings-surprise-this-quarter/39182/